N. Kapranov

A role of hypertonic saline solution in treatment of cystic fibrosis

E. Amelina, S. Krasovskiy, N. Kashirskaya, 2016 .

Safety and efficacy of Creon® micro in children with exocrine pancreatic insufficiency due to cystic fibrosis.

S. Sander-Struckmeier, V. Kovalev, N. Kashirskaya, 2015, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

High prevalence of W1282x mutation in cystic fibrosis patients from Karachay-Cherkessia.

B. Kerem, E. Ginter, A. Voronkova, 2016, Journal of Cystic Fibrosis.

Consensus “Cystic Fibrosis: definition, diagnostic criteria, treatment” Section “Microbiology and Epidemiology of chronic respiratory infections in cystic fibrosis”

I. Volkov, L. Namazova-Baranova, Намазова Лейла Сеймуровна, 2016 .

Results and prospects of screening the neonate for mucoviscidosis within the framework of the priority national project

O. Chumakova, N. Kashirskaya, N. Kapranov, 2022 .

390 Efficacy and safety of colistin for inhalation in children 5 years old and younger with cystic fibrosis with Pseudomonas aeruginosa infection

N. Kapranov, V. Nikonova, E. Zhekayte, 2011 .

Characterization of genotypes for Burkholderia cepacia complex strains isolated from patients in hospitals of the Russian federation

A. Chuchalin, O. Voronina, M. Kunda, 2013, Molecular Genetics, Microbiology and Virology.

The National Consensus Project* «Cystic Fibrosis: Definition, Diagnostic Criteria, and Therapy». Section «Inhalation Therapy» (Abridged)

I. Volkov, L. Namazova-Baranova, L. А. Shabalova, 2014 .